Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Protein Responsible for 'Bad' Blood… >
Protein Responsible for 'Bad' Blood Vessel Growth Discovered

Published: July 17, 2013.
By University College London
http://www.ucl.ac.uk

The discovery of a protein that encourages blood vessel growth, and especially 'bad' blood vessels – the kind that characterise diseases as diverse as cancer, age-related macular degeneration and rheumatoid arthritis – has been reported in the journal Nature.

The team at the UCL Institute of Ophthalmology discovered the new protein, called LRG1, by screening for mouse genes that are over-expressed in abnormal retinal blood vessels in diseased eyes.

In these diseased retinas the LRG1 protein is expressed by blood vessel endothelial cells, which line blood vessel walls. LRG1 is also present in the eyes of patients with proliferative diabetic retinopathy – a vascular complication of diabetes that can lead to blindness.

The study shows that, in mouse models, LRG1 promotes the growth of blood vessels in a process known as 'angiogenesis'. Conversely, inhibition of LRG1 in mouse models reduces the harmful blood vessel growth associated with retinal disease.

The authors of the study suggest that blocking LRG1's activity is a promising target for future therapy.

Professor John Greenwood, senior author of the research from the UCL Institute of Ophthalmology said: "We have discovered that a secreted protein, LRG1, promotes new blood vessel growth and its inhibition prevents pathological blood vessel growth in ocular disease.

"Our findings suggest that LRG1 has less of a role in normal blood vessel growth and so may be particularly applicable to 'bad' blood vessel growth. This makes LRG1 an especially attractive target for therapeutic intervention in conditions where vessel growth contributes to disease."

Angiogenesis is an essential biological process that is required for development, reproduction and the repair of damaged tissues. However angiogenesis also plays a major role in many diseases where new vessel growth can be harmful.

For example, in the retina uncontrolled and irregular blood vessel growth in diseases such as age-related macular degeneration and diabetic retinopathy can result in a catastrophic loss of vision. Another example is the growth of cancerous solid tumours, which are dependent on the proliferation of new blood vessels. Angiogenesis is also an important feature of rheumatoid arthritis, where it contributes to the inflammation of the joint.

In previous studies, many signaling molecules have been identified that control angiogenesis, with the secreted protein vascular endothelial growth factor (VEGF) being considered as the master regulator. Therapeutic targeting of VEGF has resulted in improved outcomes in eye diseases with vascular complications and in some cancers but it is clear that additional therapeutic targets need to be identified.

The mechanism through which LRG1 promotes angiogenesis is by modifying the signalling of a multifunctional secreted growth factor called transforming growth factor beta (TGF-beta). TGF-beta regulates both the maintenance of normal healthy blood vessels, and the unwanted growth of harmful blood vessels, but precisely how it promotes two opposing outcomes is a biological paradox.

This study indicates that in the retinal diseases investigated LRG1 production is 'turned on' in blood vessels. This causes a switch in TGF-beta signalling away from a normal vessel maintenance pathway towards a pathway that promotes the growth of new harmful blood vessels.

Professor Stephen Moss, senior author from the UCL Institute of Ophthalmology said: "Genetic studies have revealed that the gene that codes for LRG1 is conserved in vertebrates, and this study confirms that mouse and human blood vessels express LRG1.

"We predict, therefore, that abnormal blood vessel growth is also a conserved process and that the role of LRG1 is equally applicable to human pathological angiogenesis."

He added: "Work is already underway to develop a therapeutic antibody that targets LRG1."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Blood 
3/10/12 
Brain Cancer Blood Vessels Not Substantially Tumor-derived, Johns Hopkins Scientists Report
By Johns Hopkins Medical Institutions
Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based …
Lymphatic 
10/14/10 
University of East Anglia Makes Cancer Breakthrough
By University of East Anglia
Scientists at the University of East Anglia have made an important breakthrough in the way anti-cancer drugs are tested. A tumour cannot grow to a large size or …
Vessels 
5/13/11 
UT Southwestern Researchers Find Protein That Might Be Key to Cutting Cancer Cells' Blood Supply
By UT Southwestern Medical Center
DALLAS – May 12, 2011 – UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep …
Brain 
10/1/13 
Tests in Mice Identify Compound That May Keep Survivors of Brain Aneurysms from Succumbing to Stroke
By Johns Hopkins Medicine
Johns Hopkins researchers, working with mice, say they have identified a chemical compound that reduces the risk of dangerous, potentially stroke-causing blood vessel spasms that often occur after the …
Vessels 
4/23/12 
Making Human Textiles: Research Team Ups the Ante with Development of Blood Vessels Woven
By Federation of American Societies for Experimental Biology
A lot of people were skeptical when two young California-based researchers set out more than a decade ago to create a completely human-derived alternative to the synthetic blood vessels …
Blood 
9/19/12 
★★★ 
Research Suggests Promise of Cell Therapy for Bowel Disease
By Wake Forest Baptist Medical Center
WINSTON-SALEM, N.C. – Sept. 19, 2012 – New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the …
Vessels 
8/13/12 
Protein That Helps Tumor Blood Vessels Mature Could Make Cancer Drugs More Effective
By Sanford-Burnham Medical Research Institute
ORLANDO, Fla., August 13, 2012 – To survive, tumors need blood supply to provide them with nutrients and oxygen. To get that supply, cancer cells stimulate new blood vessel …
Melanoma 
2/26/14 
Sunburns Strike Twice
By University of Bonn
Melanoma is particularly dangerous because it can form metastases in vital organs such as the lungs, liver or brain. UV radiation is considered to be the most significant triggering …
Blood 
7/29/10 
Snake Venom Studies Yield Insights for Development of Therapies for Heart Disease And Cancer
By American Society for Biochemistry and Molecular Biology
BETHESDA, Md., July 29, 2010 – Researchers seeking to learn more about stroke by studying how the body responds to toxins in snake venom are this week releasing new …
Important 
11/28/11 

Cell Molecule Identified as Central Player in the Formation of New Blood Vessels
By University of North Carolina School of Medicine
Macrophages 
4/2/13 
Targeting Cholesterol Buildup in Eye May Slow Age-related Vision Loss
By National Eye Institute
Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans, according …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition